View Future GrowthReflect Scientific 過去の業績過去 基準チェック /06Reflect Scientificの過去数年間の業績に関するデータが不十分です。主要情報n/a収益成長率n/aEPS成長率Life Sciences 業界の成長21.51%収益成長率n/a株主資本利益率n/aネット・マージンn/a前回の決算情報30 Sep 2024最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • May 20Reflect Scientific Strengthens Position in Booming AI Data Center Cooling Market with Patented Cryogenic InnovationsReflect Scientific, Inc. highlighted how its patented solutions are uniquely positioned to address the growing global demand for advanced data center cooling, driven by the explosive growth of AI and hyperscale computing. The global data center cooling market is expected to reach $42-56 billion by 2030, expanding at a double-digit annual growth rate. Soaring compute demands from AI workloads, tightening sustainability regulations, and expanding hyperscale facilities force data center operators to rethink traditional cooling methods. Reflect's patented cryogenic cooling technologies directly target these emerging needs by offering ultra-efficient, low-temperature solutions designed for high-density AI environments. Reflect's innovations are especially timely as data centers now consume roughly 1-2% of global electricity, with projections that AI-dedicated centers could more than double their energy use by 2026. Major industry players are making bold moves to meet this challenge. For example, Samsung Electronics recently acquired cooling manufacturer FlaktGroup for $1.7 billion to strengthen its AI data center cooling position. This strategic activity highlights the urgent global demand for advanced cooling solutions, where Reflect Scientific's cryogenic technologies offer a differentiated and potentially disruptive answer. Cryogenic cooling is emerging as the next frontier for extreme-density computing, with research showing that cooling chips to cryogenic temperatures can double their efficiency. Major players, including academic institutions and hyperscale operators, are already exploring sub-zero cooling technologies for specialized AI and quantum computing deployments -- markets where Reflect Scientific's expertise and patents place it at the forefront. Reflect Scientific's patented technologies complement other advances in the sector, such as the rapid adoption of liquid cooling and immersion cooling, but offer advantages for the most thermally intensive AI "factories" of the future.お知らせ • May 14Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic InnovationReflect Scientific, Inc. announced a U.S. Patent for its innovative system to cool computer rooms using cryogenic methods. This development addresses the growing challenge of heat management in data centers and server farms, especially as artificial intelligence and cloud computing dramatically increase computing loads and energy consumption. The patented "Room Portable Blast Chiller" introduces a fast-response, energy-efficient system that uses liquid nitrogen to rapidly cool overheated spaces in IT environments. It is instrumental during power surges, peak usage times, or brownout conditions threatening sensitive computing hardware. Key features of the new system include: A compact, portable blast chiller that can reduce a room's temperature in minutes--no external electrical connection required. A patented heat exchanger design that delivers rapid cooling without flow restrictions. A version mountable to a wall for fixed installations, ideal for permanent server room integration. This advancement reinforces Reflect Scientific's commitment to cutting-edge cryogenic systems that serve the biotechnology, pharmaceutical, and IT infrastructure sectors.お知らせ • Mar 15Reflect Scientific, Inc. Files Form 15Reflect Scientific, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Common stock was $0.01 per share.お知らせ • Oct 25Reflect Scientific Inc. Announces Successful Testing of Liquid Nitrogen Temperature Control TechnologyReflect Scientific, Inc. announced the successful testing of its liquid nitrogen temperature control technology, offering a promising alternative to hydrofluorocarbon (HFC) refrigerants in building air conditioning systems. The Environmental Protection Agency's increased restrictions on using HFCs – potent greenhouse gases found in standard refrigerators and air conditioning systems – have propelled the search for sustainable alternatives. In response, RSI, having recently secured a patent for using liquid nitrogen or liquid air in cooling systems, undertook intensive testing to validate its effectiveness as a substitute for HFCs. Results conclusively demonstrated the technology's capability to accurately and reliably control temperatures across residential and industrial applications. Having already established a reputation for its ultra-low temperature freezer and chiller products in sectors including Pharmaceutical, Biotechnology, and Nutraceuticals, RSI has been at the forefront of eliminating the need for HFCs. With this latest development, the Company expands its reach, introducing its patented technology to broader sectors. This effort encompasses cold chain management fields like Reefer transportation trucks and air freight containers, Cryostats, and the recent focus on residential and commercial refrigeration and air conditioning.お知らせ • Jul 20California Air Resources Board Recent Amendments to the Airborne Toxic Control Measure for Reefer Transportation Units Favors Reflect Scientific’s Cryogenic Clean Air Reefer’SReflect Scientific, Inc. announced the California Air Resources Board has recently amended California’s regulations to favor the Cryometrix CB 40 cold transportation trailer opening the door to adoption. Transport refrigeration trailers (aka Reefers) emit multiple air pollutants, including diesel particulate matter, fine particulate matter, oxides of nitrogen, and greenhouse gases. Reefers typically operate at refrigerated warehouses or distribution centers, grocery stores, seaport facilities, and intermodal railyards and are used for the temperature-controlled transportation of perishable goods. Refrigerated trucks haul over 90 percent of the food Americans eat, and there are more than 500,000 refrigerated trailers in service in the United States. Key elements of the amendment include the use of a lower global warming potential refrigerant and more stringent particulate emission standards. These elements can be addressed with the Cryometrix CB 40 system, which utilizes a proven and patented liquid nitrogen temperature control technology, avoiding the need for diesel-driven compressor units that employ HFC-type refrigerants.お知らせ • Feb 10Reflect Scientific, Inc. Announces Continue Strong Orders with an Additional $231,000 in Cryometrix Brand Ultra-Low Temperature FreezersReflect Scientific, Inc. announced continued strong orders with an additional $231,000 in Cryometrix brand ultra-low temperature freezers. The Cryometrix line of ultra-low temperature freezers uses patented liquid nitrogen cooling technology to achieve cooling rates and system reliability far exceeding current freezer technologies. The Cryometrix ultra-low temperature freezers are available from a 120 liter chest to a front opening unit with 950 liters of capacity.お知らせ • Feb 02Reflect Scientific, Inc. Announces New Ultra-Low Temperature Freezer Addition to the CryometrixReflect Scientific, Inc. announced a new ultra-low temperature freezer addition to the Cryometrix product line that can be rapidly deployed in a transportable, self-powered configuration. The new Cryometrix RDC-120 freezer is sized explicitly for storing smaller quantities of vaccines and high-value biologicals. Designed with the same patented liquid nitrogen cooling technology as the very successful larger freezers, the RDC-120 can be installed at a fixed site or configured for entirely self-contained operation. This versatility makes it ideal for field deployment, temporary or permanent cold storage, or a transportable low-temperature storage unit. The internal storage capacity is approximately 120 liters and has a temperature storage range of 0C to -160C. Cooldown from room temperature to -80C takes a short 5 minutes. Return to a set temperature of -80C after door opening is a speedy 2 minutes protecting valuable payloads such as the Pfizer COVID vaccine from damaging temperature swings.お知らせ • Jan 14Reflect Scientific Inc Receives Sales Contract for Cryometrix FreezersReflect Scientific, Inc. announced a $416K sales contract for Cryometrix B-90 blast freezers from a prominent pharmaceutical company. A significant $416K order has been placed for Cryometrix B-90 blast freezers destined to ship to the US and the British Isles. The Cryometrix B-90 blast freezer is an ultra-cold refrigeration product that can rapidly cool the payload bay from +20C (68F) to -80C (-130F) in 7 minutes. The freezer technology covered under several patents uses a closed liquid nitrogen system keeping the liquid nitrogen from contact with the payload and personnel. The B-90 freezer is used in the process of creating and storing the newest biopharmaceuticals and mRNA vaccines.お知らせ • Dec 16Reflect Scientific Inc. Adds Another Low Temperature Refrigeration Patent Solution to Its Growing Intellectual Property Portfolio, and Business UpdateReflect Scientific, Inc. announced that an additional patent has been granted by United States Patent Office for an ultra-low temperature (-160C) chest freezer based on the proven Cryometrix liquid nitrogen cooling technology. Ultra-low temperature mechanical freezers face unique issues. Lack of temperature uniformity throughout the storage volume can be a problem for both upright and chest freezers. Opening and closing the door creates a large influx of warm air causing an extended temperature recovery time. Reflect Scientific has already addressed this concern for upright freezers with its unique liquid nitrogen based Cryometrix system. A recently issued Reflect Scientific patent now addresses these concerns with a superior chest freezer design. The Cryometrix chest freezer temperature stability and resistance to warm air infiltration during opening provides a very consistent, controlled low temperature environment that can be relied upon for safely storing high value products such as CAR-T therapeutics. This patented technology provides the next level of temperature uniformity and control. The cold chain management of COVID vaccines continues to present challenges in storage and distribution; and believe patented freezer technology could have a favorable and positive impact on the current pandemic and would be a valuable asset for the distribution and storage of the current COVID-19 vaccines that require storage at extremely cold temperatures. On sales front, have several freezer systems scheduled for shipment this year, with a number of other orders anticipated in the first quarter of 2021 from multiple worldwide pharmaceutical companies; are pleased with the level of activity are seeing, and remain optimistic that the Company may realize positive earnings per share for 2020. The Company is presently debt free. In the area of cold chain management, are continuing discussions with a major supplier of air transport containers regarding the integration of liquid nitrogen systems to enable cooling and temperature control of sensitive payloads. Company are still awaiting response from Operation Warp Speed, a FEMA contractor, and other organizations, from who have received inquiries for Cryometrix S-90 cryogenic shipping and storage system. These systems can also serve as a cold (e.g. -80C) storage unit once at destination. do have a large-scale manufacturing capability should these inquires firm up. In terms of the competitive advantages of products, believe the Cryometrix liquid nitrogen freezers offer the following principal benefits versus mechanically driven ULT's or the utilization of dry ice. They can: (i) accommodate a wide range of temperature storage conditions (i.e. anywhere from room temperature to as low as -90C); (ii) have a very rapid temperature recovery from door openings, making it safer, for example, in maintaining COVID vaccines at the desired critical temperature; and (iii) the Cryometrix liquid nitrogen system has a very high operational reliability, keeping potential waste of valuable payloads to essentially zero compared to mechanically driven freezers that can be susceptible to failure. Company do not require dry ice, which has temperature limitations. Dry ice is limited to -78.5C (the current Pfizer vaccine has been reported to require -80C); and dry ice can also present challenges with respect to handling. On the other hand, liquid nitrogen in the Cryometrix system is in a contained environment. Cryometrix freezers typically show higher storage capacity per footprint compared to mechanical freezers, and they have excellent temperature uniformity throughout the payload space with essentially no build-up of ice on payload. The newly granted patent for a “chest” freezer will be a welcome and important addition to Cryometrix freezers.お知らせ • Dec 03Reflect Scientific, Inc. Announces A Patent Has Been Granted by the United States Patent Office for an Ultracold Shipping and Storage Container for Transportation by Air That Uses Liquid Nitrogen Technology for CoolingReflect Scientific, Inc. announced a patent has been granted by the United States Patent Office for an ultracold shipping and storage container for transportation by air that uses liquid nitrogen technology for cooling. The large shipping system could carry many thousands of doses of vaccines and utilizes the commercially proven Cryometrix patented cooling and freezing technology that has the flexibility to provide precise temperature control across a wide range of temperatures. The system accommodates payloads ranging from those requiring conventional refrigeration to specialty products such as COVID-19 and related vaccines that may require temperatures as low as -80° centigrade (-112° Fahrenheit). Systems can be configured to provide for short or long duration shipping cycles, making it an ideal choice for cold chain management.お知らせ • Oct 13Reflect Scientific, Inc. Introduces Cryometrix Electric Powered Heavy-Duty Trucks for Pollution Free Shipping of COVID-19 VaccinesReflect Scientific, Inc. announced with several companies working towards introducing electric powered heavy-duty trucks, the Cryometrix 53-foot reefer trailer is ideally positioned to complete an all green package that replaces the diesel-powered tractor-trailers that are currently in use for transportation of goods requiring controlled temperatures. The Cryometrix technology offers a reliable, pollution-free system with a flexible wide-ranging temperature setpoint control that can be adjusted to match payload requirements. This single system approach could be an essential consideration when selecting a transportation means for shipping biologics such as COVID-19 vaccines. The Cryometrix CB-40 TRU is a pollution free refrigeration alternative to diesel-powered systems for transport trailers. The CB-40 uses a patented self-contained liquid nitrogen cooling system to achieve consistent temperature control with almost no moving parts, no noise and superior reliability. A closed, self-contained refrigeration system ensures nothing but fresh cold air enters the trailer. The system is a direct replacement for current diesel systems and is easily retrofitted into an existing trailer. Not only is there no diesel engine, there is also no compressor. Fewer moving parts contribute to a significantly reduced maintenance requirement. System weight is comparable to diesel systems. The Cryometrix system was proven in demonstration runs from Salt Lake City to Los Angeles and Denver. A challenging first test -- to maintain refrigeration in a 53-foot trailer filled with perishable goods traveling round trip from Salt Lake City, UT to Los Angeles, CA. The unit performed beyond expectations. The goods were delivered with no loss and no significant problems with the system. The 1323 mile road test proved successful. The second successful test involved the transportation of frozen foodstuffs to Denver. Frozen ravioli, lasagna, corn dogs, and for desert ice cream and popsicles were all loaded into a 53-foot trailer in Salt Lake City. Exactly 525 miles, seven stops and 24 hours later, the trailer, now empty, sat quietly in Denver, still maintaining the temperature at -15 F. This was a tough test for the system as maintaining products frozen at -15 F is challenging, the outside air temperature was varying and there were multiple stops where cargo was unloaded.収支内訳Reflect Scientific の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:RSCF 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費30 Sep 24201030 Jun 24201031 Mar 24101031 Dec 23101030 Sep 23101030 Jun 231-11031 Mar 23201031 Dec 22201030 Sep 22211030 Jun 22311031 Mar 22311031 Dec 21311030 Sep 21311030 Jun 21311031 Mar 21211031 Dec 20311030 Sep 20301030 Jun 20201031 Mar 20201031 Dec 19201030 Sep 19101030 Jun 19101031 Mar 19101031 Dec 18201030 Sep 181-11030 Jun 181-11031 Mar 18101031 Dec 17101030 Sep 17101030 Jun 17101031 Mar 17101031 Dec 16101030 Sep 16101030 Jun 16101031 Mar 16111031 Dec 15111030 Sep 15102030 Jun 151020質の高い収益: RSCF 非現金収入 のレベルが高いです。利益率の向上: RSCFの 利益率 が過去 1 年間で改善したかどうかを判断するにはデータが不十分です。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: RSCFの過去 5 年間の前年比収益成長率がプラスであったかどうかを判断するにはデータが不十分です。成長の加速: RSCFの過去 1 年間の収益成長を 5 年間の平均と比較するにはデータが不十分です。収益対業界: RSCFの過去 1 年間の収益成長がLife Sciences業界平均を上回ったかどうかを判断するにはデータが不十分です。株主資本利益率高いROE: RSCFは現在利益が出ていないため、自己資本利益率 ( 0% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 19:17終値2026/05/22 00:00収益2024/09/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Reflect Scientific, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 20Reflect Scientific Strengthens Position in Booming AI Data Center Cooling Market with Patented Cryogenic InnovationsReflect Scientific, Inc. highlighted how its patented solutions are uniquely positioned to address the growing global demand for advanced data center cooling, driven by the explosive growth of AI and hyperscale computing. The global data center cooling market is expected to reach $42-56 billion by 2030, expanding at a double-digit annual growth rate. Soaring compute demands from AI workloads, tightening sustainability regulations, and expanding hyperscale facilities force data center operators to rethink traditional cooling methods. Reflect's patented cryogenic cooling technologies directly target these emerging needs by offering ultra-efficient, low-temperature solutions designed for high-density AI environments. Reflect's innovations are especially timely as data centers now consume roughly 1-2% of global electricity, with projections that AI-dedicated centers could more than double their energy use by 2026. Major industry players are making bold moves to meet this challenge. For example, Samsung Electronics recently acquired cooling manufacturer FlaktGroup for $1.7 billion to strengthen its AI data center cooling position. This strategic activity highlights the urgent global demand for advanced cooling solutions, where Reflect Scientific's cryogenic technologies offer a differentiated and potentially disruptive answer. Cryogenic cooling is emerging as the next frontier for extreme-density computing, with research showing that cooling chips to cryogenic temperatures can double their efficiency. Major players, including academic institutions and hyperscale operators, are already exploring sub-zero cooling technologies for specialized AI and quantum computing deployments -- markets where Reflect Scientific's expertise and patents place it at the forefront. Reflect Scientific's patented technologies complement other advances in the sector, such as the rapid adoption of liquid cooling and immersion cooling, but offer advantages for the most thermally intensive AI "factories" of the future.
お知らせ • May 14Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic InnovationReflect Scientific, Inc. announced a U.S. Patent for its innovative system to cool computer rooms using cryogenic methods. This development addresses the growing challenge of heat management in data centers and server farms, especially as artificial intelligence and cloud computing dramatically increase computing loads and energy consumption. The patented "Room Portable Blast Chiller" introduces a fast-response, energy-efficient system that uses liquid nitrogen to rapidly cool overheated spaces in IT environments. It is instrumental during power surges, peak usage times, or brownout conditions threatening sensitive computing hardware. Key features of the new system include: A compact, portable blast chiller that can reduce a room's temperature in minutes--no external electrical connection required. A patented heat exchanger design that delivers rapid cooling without flow restrictions. A version mountable to a wall for fixed installations, ideal for permanent server room integration. This advancement reinforces Reflect Scientific's commitment to cutting-edge cryogenic systems that serve the biotechnology, pharmaceutical, and IT infrastructure sectors.
お知らせ • Mar 15Reflect Scientific, Inc. Files Form 15Reflect Scientific, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Common stock was $0.01 per share.
お知らせ • Oct 25Reflect Scientific Inc. Announces Successful Testing of Liquid Nitrogen Temperature Control TechnologyReflect Scientific, Inc. announced the successful testing of its liquid nitrogen temperature control technology, offering a promising alternative to hydrofluorocarbon (HFC) refrigerants in building air conditioning systems. The Environmental Protection Agency's increased restrictions on using HFCs – potent greenhouse gases found in standard refrigerators and air conditioning systems – have propelled the search for sustainable alternatives. In response, RSI, having recently secured a patent for using liquid nitrogen or liquid air in cooling systems, undertook intensive testing to validate its effectiveness as a substitute for HFCs. Results conclusively demonstrated the technology's capability to accurately and reliably control temperatures across residential and industrial applications. Having already established a reputation for its ultra-low temperature freezer and chiller products in sectors including Pharmaceutical, Biotechnology, and Nutraceuticals, RSI has been at the forefront of eliminating the need for HFCs. With this latest development, the Company expands its reach, introducing its patented technology to broader sectors. This effort encompasses cold chain management fields like Reefer transportation trucks and air freight containers, Cryostats, and the recent focus on residential and commercial refrigeration and air conditioning.
お知らせ • Jul 20California Air Resources Board Recent Amendments to the Airborne Toxic Control Measure for Reefer Transportation Units Favors Reflect Scientific’s Cryogenic Clean Air Reefer’SReflect Scientific, Inc. announced the California Air Resources Board has recently amended California’s regulations to favor the Cryometrix CB 40 cold transportation trailer opening the door to adoption. Transport refrigeration trailers (aka Reefers) emit multiple air pollutants, including diesel particulate matter, fine particulate matter, oxides of nitrogen, and greenhouse gases. Reefers typically operate at refrigerated warehouses or distribution centers, grocery stores, seaport facilities, and intermodal railyards and are used for the temperature-controlled transportation of perishable goods. Refrigerated trucks haul over 90 percent of the food Americans eat, and there are more than 500,000 refrigerated trailers in service in the United States. Key elements of the amendment include the use of a lower global warming potential refrigerant and more stringent particulate emission standards. These elements can be addressed with the Cryometrix CB 40 system, which utilizes a proven and patented liquid nitrogen temperature control technology, avoiding the need for diesel-driven compressor units that employ HFC-type refrigerants.
お知らせ • Feb 10Reflect Scientific, Inc. Announces Continue Strong Orders with an Additional $231,000 in Cryometrix Brand Ultra-Low Temperature FreezersReflect Scientific, Inc. announced continued strong orders with an additional $231,000 in Cryometrix brand ultra-low temperature freezers. The Cryometrix line of ultra-low temperature freezers uses patented liquid nitrogen cooling technology to achieve cooling rates and system reliability far exceeding current freezer technologies. The Cryometrix ultra-low temperature freezers are available from a 120 liter chest to a front opening unit with 950 liters of capacity.
お知らせ • Feb 02Reflect Scientific, Inc. Announces New Ultra-Low Temperature Freezer Addition to the CryometrixReflect Scientific, Inc. announced a new ultra-low temperature freezer addition to the Cryometrix product line that can be rapidly deployed in a transportable, self-powered configuration. The new Cryometrix RDC-120 freezer is sized explicitly for storing smaller quantities of vaccines and high-value biologicals. Designed with the same patented liquid nitrogen cooling technology as the very successful larger freezers, the RDC-120 can be installed at a fixed site or configured for entirely self-contained operation. This versatility makes it ideal for field deployment, temporary or permanent cold storage, or a transportable low-temperature storage unit. The internal storage capacity is approximately 120 liters and has a temperature storage range of 0C to -160C. Cooldown from room temperature to -80C takes a short 5 minutes. Return to a set temperature of -80C after door opening is a speedy 2 minutes protecting valuable payloads such as the Pfizer COVID vaccine from damaging temperature swings.
お知らせ • Jan 14Reflect Scientific Inc Receives Sales Contract for Cryometrix FreezersReflect Scientific, Inc. announced a $416K sales contract for Cryometrix B-90 blast freezers from a prominent pharmaceutical company. A significant $416K order has been placed for Cryometrix B-90 blast freezers destined to ship to the US and the British Isles. The Cryometrix B-90 blast freezer is an ultra-cold refrigeration product that can rapidly cool the payload bay from +20C (68F) to -80C (-130F) in 7 minutes. The freezer technology covered under several patents uses a closed liquid nitrogen system keeping the liquid nitrogen from contact with the payload and personnel. The B-90 freezer is used in the process of creating and storing the newest biopharmaceuticals and mRNA vaccines.
お知らせ • Dec 16Reflect Scientific Inc. Adds Another Low Temperature Refrigeration Patent Solution to Its Growing Intellectual Property Portfolio, and Business UpdateReflect Scientific, Inc. announced that an additional patent has been granted by United States Patent Office for an ultra-low temperature (-160C) chest freezer based on the proven Cryometrix liquid nitrogen cooling technology. Ultra-low temperature mechanical freezers face unique issues. Lack of temperature uniformity throughout the storage volume can be a problem for both upright and chest freezers. Opening and closing the door creates a large influx of warm air causing an extended temperature recovery time. Reflect Scientific has already addressed this concern for upright freezers with its unique liquid nitrogen based Cryometrix system. A recently issued Reflect Scientific patent now addresses these concerns with a superior chest freezer design. The Cryometrix chest freezer temperature stability and resistance to warm air infiltration during opening provides a very consistent, controlled low temperature environment that can be relied upon for safely storing high value products such as CAR-T therapeutics. This patented technology provides the next level of temperature uniformity and control. The cold chain management of COVID vaccines continues to present challenges in storage and distribution; and believe patented freezer technology could have a favorable and positive impact on the current pandemic and would be a valuable asset for the distribution and storage of the current COVID-19 vaccines that require storage at extremely cold temperatures. On sales front, have several freezer systems scheduled for shipment this year, with a number of other orders anticipated in the first quarter of 2021 from multiple worldwide pharmaceutical companies; are pleased with the level of activity are seeing, and remain optimistic that the Company may realize positive earnings per share for 2020. The Company is presently debt free. In the area of cold chain management, are continuing discussions with a major supplier of air transport containers regarding the integration of liquid nitrogen systems to enable cooling and temperature control of sensitive payloads. Company are still awaiting response from Operation Warp Speed, a FEMA contractor, and other organizations, from who have received inquiries for Cryometrix S-90 cryogenic shipping and storage system. These systems can also serve as a cold (e.g. -80C) storage unit once at destination. do have a large-scale manufacturing capability should these inquires firm up. In terms of the competitive advantages of products, believe the Cryometrix liquid nitrogen freezers offer the following principal benefits versus mechanically driven ULT's or the utilization of dry ice. They can: (i) accommodate a wide range of temperature storage conditions (i.e. anywhere from room temperature to as low as -90C); (ii) have a very rapid temperature recovery from door openings, making it safer, for example, in maintaining COVID vaccines at the desired critical temperature; and (iii) the Cryometrix liquid nitrogen system has a very high operational reliability, keeping potential waste of valuable payloads to essentially zero compared to mechanically driven freezers that can be susceptible to failure. Company do not require dry ice, which has temperature limitations. Dry ice is limited to -78.5C (the current Pfizer vaccine has been reported to require -80C); and dry ice can also present challenges with respect to handling. On the other hand, liquid nitrogen in the Cryometrix system is in a contained environment. Cryometrix freezers typically show higher storage capacity per footprint compared to mechanical freezers, and they have excellent temperature uniformity throughout the payload space with essentially no build-up of ice on payload. The newly granted patent for a “chest” freezer will be a welcome and important addition to Cryometrix freezers.
お知らせ • Dec 03Reflect Scientific, Inc. Announces A Patent Has Been Granted by the United States Patent Office for an Ultracold Shipping and Storage Container for Transportation by Air That Uses Liquid Nitrogen Technology for CoolingReflect Scientific, Inc. announced a patent has been granted by the United States Patent Office for an ultracold shipping and storage container for transportation by air that uses liquid nitrogen technology for cooling. The large shipping system could carry many thousands of doses of vaccines and utilizes the commercially proven Cryometrix patented cooling and freezing technology that has the flexibility to provide precise temperature control across a wide range of temperatures. The system accommodates payloads ranging from those requiring conventional refrigeration to specialty products such as COVID-19 and related vaccines that may require temperatures as low as -80° centigrade (-112° Fahrenheit). Systems can be configured to provide for short or long duration shipping cycles, making it an ideal choice for cold chain management.
お知らせ • Oct 13Reflect Scientific, Inc. Introduces Cryometrix Electric Powered Heavy-Duty Trucks for Pollution Free Shipping of COVID-19 VaccinesReflect Scientific, Inc. announced with several companies working towards introducing electric powered heavy-duty trucks, the Cryometrix 53-foot reefer trailer is ideally positioned to complete an all green package that replaces the diesel-powered tractor-trailers that are currently in use for transportation of goods requiring controlled temperatures. The Cryometrix technology offers a reliable, pollution-free system with a flexible wide-ranging temperature setpoint control that can be adjusted to match payload requirements. This single system approach could be an essential consideration when selecting a transportation means for shipping biologics such as COVID-19 vaccines. The Cryometrix CB-40 TRU is a pollution free refrigeration alternative to diesel-powered systems for transport trailers. The CB-40 uses a patented self-contained liquid nitrogen cooling system to achieve consistent temperature control with almost no moving parts, no noise and superior reliability. A closed, self-contained refrigeration system ensures nothing but fresh cold air enters the trailer. The system is a direct replacement for current diesel systems and is easily retrofitted into an existing trailer. Not only is there no diesel engine, there is also no compressor. Fewer moving parts contribute to a significantly reduced maintenance requirement. System weight is comparable to diesel systems. The Cryometrix system was proven in demonstration runs from Salt Lake City to Los Angeles and Denver. A challenging first test -- to maintain refrigeration in a 53-foot trailer filled with perishable goods traveling round trip from Salt Lake City, UT to Los Angeles, CA. The unit performed beyond expectations. The goods were delivered with no loss and no significant problems with the system. The 1323 mile road test proved successful. The second successful test involved the transportation of frozen foodstuffs to Denver. Frozen ravioli, lasagna, corn dogs, and for desert ice cream and popsicles were all loaded into a 53-foot trailer in Salt Lake City. Exactly 525 miles, seven stops and 24 hours later, the trailer, now empty, sat quietly in Denver, still maintaining the temperature at -15 F. This was a tough test for the system as maintaining products frozen at -15 F is challenging, the outside air temperature was varying and there were multiple stops where cargo was unloaded.